CAS 2377916-66-8

PD-1/PD-L1-IN-NP19

CAS: 2377916-66-8

PD-1/PD-L1-IN-NP19

Fórmula: C₃₃H₃₁ClN₂O₄

Pureza: ≥95%

Peso molecular: 555.06

Ref: 54-BUP23735

NP19

CAS: 2377916-66-8

NP19 is a Chinese medicinal compound that has been found to have potent anticancer properties. It is an analog of kinase inhibitors and has been shown to induce apoptosis in cancer cells. NP19 works by inhibiting protein kinases, which are enzymes that play a crucial role in the growth and proliferation of tumor cells. This compound has been extensively studied for its potential use as an anticancer drug and has shown promising results in preclinical studies. In addition, NP19 can be detected in human urine, indicating that it may have potential as a non-invasive diagnostic tool for cancer. Overall, NP19 represents a promising new avenue for the development of effective cancer therapies.

Fórmula: C₃₃H₃₁ClN₂O₄

Pureza: Min. 95%

Peso molecular: 555.1 g/mol

Ref: 3D-CVD91666

PD-1/PD-L1-IN-NP19

CAS: 2377916-66-8

PD-1/PD-L1-IN-NP19: a PD-1/PD-L1 inhibitor with 12.5 nM IC50, may boost antitumor immunity.

Fórmula: C₃₃H₃₁ClN₂O₄

Pureza: 96.70%

Forma y color: White Solid

Peso molecular: 555.06

Ref: TM-T36900